Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

RPS: Pharmacist for every care home could save NHS £135m

Pharmacists should conduct regular medicines reviews in care homes and train staff, the RPS says

Aligning a pharmacist with every care home could save the NHS £135 million a year, according to a new report from the Royal Pharmaceutical Society (RPS).

A review of three local pilots has suggested that pharmacist medication reviews could save £60m a year by optimising patients’ medicines use, the RPS said. A further £75m could be saved by keeping care home patients out of hospital, it said.

One pharmacist, working with a single GP, should “take charge” of medicines use in each care home, the society suggested.

Local commissioners should pay pharmacists to provide regular medicine reviews and train staff to improve medicines safety in care homes, it said in The Right Medicine: Improving Care in Care Homes report, published today (February 23).

“This will help to solve the issue of medicines waste, improve efficiency and provide better health outcomes for care home residents,” the RPS said.

Embedding a pharmacist within a care home's multidisciplinary team would ensure "consistently high care", the RPS said. Community pharmacists are “ideally placed” to take on this new role, it told C+D this week.

England's chief pharmaceutical officer Keith Ridge said he looked forward to "exploring the proposals further". "It is important that pharmacists are given the opportunity to use their skills to support care home residents," he said.

The proposals in detail

The RPS said pharmacists could particularly help with reviewing the use of psychotropic drugs in care – including antipsychotics – to ensure their use is kept to a minimum.

Pharmacists, prescribers, and care home providers should work together to formalise plans for patients’ end-of-life care, it said. Where a care home specialises in a certain type of care – such as dementia – the pharmacist involved should ensure they are competent in this area, the RPS said.

To establish this new role, clinical commissioning groups (CCGs) should create a blueprint for “what good pharmaceutical care in residential homes looks like”, it said. CCGs or care homes themselves should agree contracts for pharmacists to provide additional professional services, the RPS added.

The GP view

The Royal College of General Practitioners (RCGP) said the concept of allocating one pharmacist per care home is “worth exploring”, and could help reduce pressure on GPs. “We welcome the opportunity to further develop the valuable relationship that GPs have with our pharmacy colleagues.

“Managing polypharmacy effectively is key to ensuring our patients in care homes are kept safe and only take the medicines they need,” RCGP chair Maureen Baker said.

 

How closely do you work with local care homes?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD007994

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel